These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8868040)

  • 1. The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment.
    Johannesson M
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S23-6. PubMed ID: 8868040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaco-economic aspects of the treatment of hypertension].
    Delporte JP; Rorive G
    Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit aspects of treatment of hypertension in the elderly.
    Lindholm LH; Johannesson M
    Blood Press Suppl; 1995; 3():11-4. PubMed ID: 8535536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
    Keiding H; Hildebrandt P; Burke T; Carides GW
    Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of the switch towards more expensive antihypertensive drugs.
    Johannesson M
    Health Policy; 1994 Mar; 28(1):1-13. PubMed ID: 10136603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stroke prevention with a high risk strategy of treating hypertension in patients after a transient ischemic attack].
    Brainin M; Dachenhausen A; Steiner MM
    Wien Med Wochenschr; 1997; 147(2):34-6. PubMed ID: 9139469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit of treating hypertension.
    Jönsson BG
    J Hypertens Suppl; 1994 Dec; 12(10):S65-70. PubMed ID: 7769494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
    Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A health-economic comparison of diet and drug treatment in obese men with mild hypertension.
    Johannesson M; Fagerberg B
    J Hypertens; 1992 Sep; 10(9):1063-70. PubMed ID: 1328366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost effectiveness of hypertension treatment in Sweden.
    Johannesson M
    Pharmacoeconomics; 1995 Mar; 7(3):242-50. PubMed ID: 10155314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.